Hidden Threats: Unmasking Tropical Diseases and Viral Infections in Migrant Communities
"A new study reveals the alarming rates of coinfection among detained migrants, highlighting critical gaps in healthcare and public health strategies."
Imagine navigating a new life in a foreign land, only to face health challenges you never anticipated. For many migrants, especially those from sub-Saharan Africa and Latin America, this is a harsh reality. Often, they carry with them not only hopes and dreams, but also persistent tropical diseases and viral infections that can remain hidden for years.
A recent study conducted in a Swiss pretrial prison sheds light on this critical issue. The research uncovers surprisingly high rates of coinfections—individuals infected with both parasitic neglected tropical diseases (NTDs) and viral infections like HIV, hepatitis B (HBV), and hepatitis C (HCV). These findings expose significant gaps in our healthcare systems and public health approaches when it comes to addressing the unique health needs of migrant communities.
This article delves into the details of the study, exploring the prevalence and impact of these coinfections. It also emphasizes the urgent need for targeted interventions and control strategies to protect vulnerable populations and prevent further spread of these diseases.
What Surveillance and Testing Can Show
A CDC report summarizes health data reported to the Electronic Disease Notification system for refugees, immigrants, and eligible others who arrived in the United States during 2014–2019. CDC guidance cautions that stool ova and parasite testing lacks sensitivity for Strongyloides and should not be used to rule out infection. Together, these sources describe a defined surveillance cohort and a diagnostic limitation, rather than providing an overall prevalence figure for migrant communities.
Screening Amid Fragmented Evidence
A 2026 umbrella review of systematic reviews describes cross-disease evidence on imported mosquito-borne infectious diseases as fragmented and says it aims to identify gaps relevant to clinical practice and research priorities. A 2019 article reports that migrants may face infectious-disease risks during different phases of migration because of pathogen exposure, barriers to healthcare access, treatment interruptions, and poor nutrition and living conditions. These sources point to both gaps in the evidence base and practical challenges affecting migrant health.
Disease and Movement Across History
A 2024 study examines historical disease transmission in connection with colonialization, the slave trade, the spread of religion, and transcontinental and island trade. It names leprosy, the Black Death, syphilis, malaria, Spanish flu, and COVID-19 as diseases that have contributed to global health crises. The study’s description appears in both its ResearchGate listing and its Taylor & Francis listing.
Why Are Migrant Communities Particularly Vulnerable to Coinfections?
Migrant populations often face a unique set of challenges that increase their vulnerability to infectious diseases. Several factors contribute to this heightened risk:
- Endemic Regions: Many migrants originate from regions where tropical diseases and viral infections are widespread. They may have been exposed to these diseases in their home countries, where they can persist for years without causing noticeable symptoms.
- Silent Infections: Diseases like schistosomiasis and strongyloidiasis (both NTDs), as well as viral infections like HBV and HCV, can remain asymptomatic for long periods. This means that individuals may be unaware they are infected, delaying diagnosis and treatment.
- Limited Access to Healthcare: Migrants often face barriers to accessing healthcare in their new host countries. These barriers can include language difficulties, cultural differences, financial constraints, and lack of health insurance.
- Vulnerable Settings: Detention centers, in particular, can be breeding grounds for infectious diseases. Overcrowding, poor sanitation, and limited access to healthcare create conditions that facilitate the spread of infections.
A European Meta-Analysis of Migrant NTDs
A study published in February 2025 describes itself as the first meta-analysis of neglected tropical disease prevalence among migrants across European nations. It presents NTDs among migrants in Europe as a growing challenge. The study’s description also identifies limited research in this area as a compounding concern.
Gaps in Screening Evidence
A systematic review of schistosomiasis and strongyloidiasis screening in newly arrived migrants in the EU/EEA identifies a lack of accurate prevalence data and a lack of cost-effectiveness data for screening and treatment. A separate systematic review on latent tuberculosis infection reports that it found no studies directly estimating the effectiveness of LTBI screening programmes among migrants or the general population. These reviews therefore identify evidence gaps, rather than establishing that the screening approaches are ineffective.
Reported Prevalence Across Migrant Cohorts
A systematic review and meta-analysis reported median prevalence among African migrants and refugees of 6.0% for syphilis (95% CI: 2.0–7.0%), 13.0% for helminthiasis (9.5–14.5%), and 14.0% for schistosomiasis (13.0–17.0%). It also reported 15.0% for intestinal protozoa infection (10.5–21.0%), 10.0% for hepatitis B (6.0–14.0%), and 3.0% for hepatitis C (1.0–4.0%). Separately, a German cross-sectional study of unaccompanied refugee minors reported active HBV infection in 60 of 776 tested participants, or 7.7% of those tested.
Turning the Tide: Strategies for Protecting Migrant Health
The findings of the Swiss study underscore the urgent need for comprehensive and targeted interventions to address the health challenges facing migrant communities. Some key strategies include: <ul> <li><b>Enhanced Screening Programs:</b> Implement routine screening for NTDs and viral infections among migrants, particularly those originating from endemic regions. These screenings should be conducted upon arrival in the host country and regularly throughout their stay.</li> <li><b>Improved Access to Healthcare:</b> Ensure that migrants have access to affordable and culturally sensitive healthcare services. This includes providing language assistance, addressing cultural barriers, and offering health insurance options.</li> <li><b>Targeted Public Health Campaigns:</b> Develop public health campaigns that raise awareness about NTDs and viral infections among migrant communities. These campaigns should be tailored to the specific needs and cultural backgrounds of the target populations.</li> <li><b>Control Strategies in Detention Centers:</b> Implement control strategies in detention centers to prevent the spread of infectious diseases. These strategies should include improved sanitation, overcrowding reduction, and regular health screenings.</li> </ul> By implementing these strategies, we can protect vulnerable populations, prevent the spread of infectious diseases, and build a healthier and more inclusive society for all.
Include Families in Migrant Health Research
A systematic review and meta-analysis describes itself as the first comprehensive synthesis of health outcomes among migrant workers and their transnational families in the Asia–Pacific region. Its stated scope includes children, spouses, and adult relatives left behind in countries of origin, as well as migrant workers. The review thus frames family members in countries of origin as part of the health-outcome picture it examines.
Preparing for Future Disease Management
A February 2025 chapter on potential future trends in tropical disease management says anticipating those trends is critical for effective public health strategies. It situates this need in an increasingly interconnected and environmentally challenging world. The supplied description does not name specific projected trends or interventions.
Profiles to Guide Equitable Health Responses
The Pan American Health Organization calls for developing and sharing comprehensive profiles of the health status of key migrant populations. It says those profiles should include identification of risk factors. PAHO presents this information as a way to support host countries’ health-system adaptive capacity and guide equitable interventions addressing migrants’ specific health needs.